Preclinical Identification to Clinical Validation of Plasma Metabolomic Signature of Novel Signal Transduction InhibitorsFriday, 12 September 2014 at 15:25  Add to Calendar ▼2014-09-12 15:25:002014-09-12 16:25:00Europe/LondonPreclinical Identification to Clinical Validation of Plasma Metabolomic Signature of Novel Signal Transduction InhibitorsMetabomeeting 2014 in London, UKLondon, UKSELECTBIOenquiries@selectbiosciences.comUnique changes in plasma metabolite profiles were identified in preclinical tumour models with systemic modulation of the PI3K and RAS-RAF-MEK pathway that were validated in human subjects with advanced solid tumours. |
Add to Calendar ▼2014-09-10 00:00:002014-09-12 00:00:00Europe/LondonMetabomeeting 2014Metabomeeting 2014 in London, UKLondon, UKSELECTBIOenquiries@selectbiosciences.com
